Kimitaka Shiotani

Novel 2′,6′-Dimethyl-l-Tyrosine-Containing Pyrazinone Opioid Mimetic μ-Agonists with Potent Antinociceptive Activity in Mice

Yunden Jinsmaa, Yoshio Okada, Yuko Tsuda et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 44 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Bifunctional [2‘,6‘-Dimethyl-<scp>l</scp>-tyrosine]endomorphin-2 Analogues Substituted at Position 3 with Alkylated Phenylalanine Derivatives Yield Potent Mixed μ-Agonist/δ-Antagonist and Dual μ-Agonist/δ-Agonist Opioid Ligands

Tingyou Li, Kimitaka Shiotani, Anna Miyazaki et al. · Journal of Medicinal Chemistry · 2007 · 42 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Oral Bioavailability of a New Class of μ-Opioid Receptor Agonists Containing 3,6-Bis[Dmt-NH(CH₂)<i>_n</i>]-2(1<i>H</i>)-pyrazinone with Central-Mediated Analgesia

Yunden Jinsmaa, Anna Miyazaki, Yoshio Fujita et al. · Journal of Medicinal Chemistry · 2004 · 39 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse

Yunden Jinsmaa, Yoshio Fujita, Kimitaka Shiotani et al. · European Journal of Pharmacology · 2005 · 36 citations

Medicine, Pharmacology, Molecular Pharmacology +11

Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1

Yunden Jinsmaa, Ewa D. Marczak, Yoshio Fujita et al. · Pharmacology Biochemistry and Behavior · 2006 · 20 citations

Medicine, Medicinal Chemistry, Pharmacology +11